abstract |
The present invention relates to novel imidazolidine derivatives of formula (I) and pharmaceutically acceptable salts and esters thereof: Formula I Where R 1 , R 2 , R 3 , A, D and E are as defined in the specification and claims. The compound can be used as a drug by binding to LXRα and LXRβ. |